4//SEC Filing
COELHO PHILIP H 4
Accession 0001161697-22-000569
CIK 0001369568other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:00 PM ET
Size
7.5 KB
Accession
0001161697-22-000569
Insider Transaction Report
Form 4
COELHO PHILIP H
Director
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2022-12-06+1,334→ 150,887 total - Award
Restricted Stock Units
2022-12-06−1,334→ 295,500 total→ Common Stock (1,334 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001109775
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:00 PM ET
- Size
- 7.5 KB